Medical News

RSS

Palatin Technologies announces net income of $4.5M for second-quarter fiscal 2010

Palatin Technologies, Inc. today announced results for its second quarter ended December 31, 2009. Palatin reported net income of $4.5 million, or $0.04 per basic and diluted share, for the quarter ended December 31, 2009, compared to a net loss of $0.4 million, or $0.00 per basic and diluted share, for the same period in 2008. Total revenues in the quarter ended December 31, 2009 were $7.3 million, compared to $1.2 million for the same period in 2008.

16 Feb 2010

Derycz Scientific reports second-quarter and half-year fiscal 2010 results

Derycz Scientific, a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, announced its second quarter and half-year financial results for fiscal year 2010.

16 Feb 2010

EntreMed's ENMD-2076 for AML receives FDA's orphan drug designation

EntreMed, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's lead oncology drug candidate, ENMD-2076, for the treatment of acute myeloid leukemia (AML).

16 Feb 2010

AGA Medical Holdings announces fourth-quarter and full-year 2009 financial results

AGA Medical Holdings, a leading developer of interventional medical devices for the minimally invasive treatment of structural heart defects and vascular abnormalities, today reported financial results for the fourth quarter and full year ended Dec. 31, 2009.

16 Feb 2010

MAP Pharmaceuticals initiates LEVADEX-intravenous DHE comparative trial

MAP Pharmaceuticals, Inc. today announced that the Company initiated a trial to compare the pharmacokinetics (PK), safety and metabolic profiles of LEVADEX™ orally inhaled migraine therapy with intravenous dihydroergotamine mesylate (DHE) in smokers and non-smokers. LEVADEX is a novel orally inhaled migraine therapy that has completed Phase 3 efficacy development for the acute treatment of migraine.

16 Feb 2010

Merck announces global sales of $27.4 billion for full-year 2009

Merck & Co., Inc. today announced financial results for the fourth quarter and the full year of 2009 which include the results of legacy Schering-Plough operations from the close of the merger on Nov. 3, 2009 through Dec. 31, 2009.

16 Feb 2010

Delcath Systems to initiate Expanded Access Program for melphalan in patients with metastatic melanoma to the liver

Delcath Systems, Inc., which is testing its proprietary treatment system for metastatic cancers to the liver, announced today that the U.S. Food and Drug Administration ("FDA") will allow the Company to initiate an Expanded Use – Intermediate Size Population protocol for the hepatic arterial infusion of melphalan with venous filtration via the Delcath PHP System™ for patients with ocular and cutaneous melanoma metastatic to the liver.

16 Feb 2010

Childhood obesity: Strongest predictor of premature death

In a study now being published in The New England Journal of Medicine, Associate Professor Paul Franks of Umeå University in Sweden, in collaboration with researchers in the US, shows how childhood obesity, together with other risk factors for cardiovascular disease, affects premature death.

16 Feb 2010

WellPoint cancels Investor Day, schedules conference call to review 2010 financial outlook

WellPoint, Inc. today cancelled its Investor Day previously scheduled for February 23, 2010, and announced that management will review the Company's 2010 financial outlook during a conference call on March 17, 2010, at 8:30 a.m. Eastern Daylight Time (EDT). The Company continues to expect full year 2010 net income to be at least $6.00 per share, subject to its ability to secure and maintain sufficient premium rates.

16 Feb 2010

EVOLVE WELLNESS CENTER expands to prominent new space in West Hollywood

EVOLVE WELLNESS CENTER, Los Angeles’ premier Acupuncture group for more than 13 years has expanded to a prominent new space in West Hollywood and is planning to celebrate its Grand Re-Opening with a great deal of fanfare.

16 Feb 2010

First Edition: February 16, 2010

Today's health policy headlines cover a range of topics -- from using health savings to reduce the deficit to how tort reform fits into the current health reform negotiations.

16 Feb 2010

Effects of eco-toxicology on Zebra fish

Rasoul Nourizadeh-Lillabadi has shown that zebra fish can be used as models in order to study the effects of eco-toxicology on fish indigenous to Norway. The toxic substances used in the research project come from water effluent from the offshore industry and from organic material that had accumulated in the liver of burbot fish in the lakes of Mjøsa and Losna.

16 Feb 2010

NACHC: ARRA investment is making a difference in community health centers

People and communities are healthier thanks to the investment in America’s Health Centers from the American Recovery and Reinvestment Act (ARRA), or the “economic stimulus.” The law, enacted one year ago this week, provided funds that helped health centers expand care to the growing numbers of jobless and uninsured people who were quickly filling up their waiting rooms.

16 Feb 2010

'Fertility chip' to accurately count spermatozoa in sperm

A new 'fertility chip', developed by researchers at the University of Twente's MESA+ Institute for Nanotechnology, can accurately count spermatozoa in sperm. This is an important step towards the development of a compact device for reliable 'pre-scanning' of male fertility. The researchers are publishing the invention of the chip in the scientific journal Lab on a Chip.

16 Feb 2010

Ingenuity Systems releases new IPA software for life science researchers

Ingenuity® Systems, the leading provider of information solutions for life science researchers, today announced the addition of dynamic reports, new weekly content updates, and metabolomics workflow support in the latest release of IPA® software.

16 Feb 2010

SELmedia releases evidence-based program that helps HFA kids develop social skills

SELmedia announced today that it has released its newest addition to the growing suite of S.S.GRIN (Social Skills Group Intervention) programs. S.S.GRIN HFA is the first evidence-based program that teaches social skills to young children diagnosed with High Functioning Autism (HFA). The program is appropriate for use in schools, community settings and clinics.

16 Feb 2010

International Merchant Advisors signs LOI to purchase minority interest in Assured Pharmacy

International Merchant Advisors, Inc. www.imaiinc.com announced today that the company has signed a letter of intent to purchase a minority interest in Assured Pharmacy, Inc. www.assuredpharmacyinc.com, a retail pharmaceutical operation that is focused on selling prescription medications in the chronic pain management medical sector.

16 Feb 2010

BUSACC hosts breakfast panel over reconstruction opportunities in Iraq, covering healthcare and pharma

The reconstruction of Iraq is under way and opportunities for Texas businesses abound. The Bilateral U.S. – Arab Chamber of Commerce (BUSACC) is hosting a business breakfast and panel discussion featuring Iraq’s Ambassador to the United States, the Senior Commercial Counsel and a high level Ministry of Energy official and delegation, along with American risk and security mitigation experts.

16 Feb 2010

Narcolepsy is indeed an autoimmune disorder, finds University of Lausanne study

Individuals with the sleep disorder narcolepsy suffer with excessive daytime sleepiness and attacks of muscle paralysis triggered by strong emotions (a condition known as cataplexy).

16 Feb 2010

Study explores relationship between adverse events, early antecedents and CO2 reactivity in panic disorder

A study performed by a group of Italian investigators and published in the current issue of Psychotherapy and Psychosomatics has explored the relationship between adverse events, early antecedents and carbon dioxide reactivity (CO2 reactivity) in panic disorder.

16 Feb 2010

Medical News

Palatin Technologies announces net income of $4.5M for second-quarter fiscal 2010

Derycz Scientific reports second-quarter and half-year fiscal 2010 results

EntreMed's ENMD-2076 for AML receives FDA's orphan drug designation

AGA Medical Holdings announces fourth-quarter and full-year 2009 financial results

MAP Pharmaceuticals initiates LEVADEX-intravenous DHE comparative trial

Merck announces global sales of $27.4 billion for full-year 2009

Delcath Systems to initiate Expanded Access Program for melphalan in patients with metastatic melanoma to the liver

Childhood obesity: Strongest predictor of premature death

WellPoint cancels Investor Day, schedules conference call to review 2010 financial outlook

EVOLVE WELLNESS CENTER expands to prominent new space in West Hollywood

First Edition: February 16, 2010

Effects of eco-toxicology on Zebra fish

NACHC: ARRA investment is making a difference in community health centers

'Fertility chip' to accurately count spermatozoa in sperm

Ingenuity Systems releases new IPA software for life science researchers

SELmedia releases evidence-based program that helps HFA kids develop social skills

International Merchant Advisors signs LOI to purchase minority interest in Assured Pharmacy

BUSACC hosts breakfast panel over reconstruction opportunities in Iraq, covering healthcare and pharma

Narcolepsy is indeed an autoimmune disorder, finds University of Lausanne study

Study explores relationship between adverse events, early antecedents and CO2 reactivity in panic disorder

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News